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Several technrques are available for the serological analysis
of antigenic determinants on human hematopoietic progemtor
cells (HPC). However, techniques for the recogmtion of cellu-
larly defined antigens on such progenitor cells have not yet
been descnbed. We therefore developed an in vitro cellular
cytotoxicrty assay, with bone marrow cells as target cells. In
this assay specific cytotoxic Τ lymphocyte (CTL) lines are
used as effectors for cell-mediated cytolysis of bone marrow
mononuclear cells that express the antigens for which the
CTLs were primed in a mixed lymphocyte culture. As a model
we used CTL lines against HLA-A2 or -B7 determinants. By
using effector-target ratios varying from 1:2 to 4:1, 4 hr of
incubation of these CTL lines with bone marrow mononuclear
cells from HLA-A2 or -B7 positive donors resulted in a specific
dose-dependent growth Inhibition up to 100% of myeloid
(CFU-GM), erythroid (BFU-E), and multipotenöal (CFU-GEMM)
HPC. In contrast, no Inhibition of HPC was observed using
mononuclear bone marrow cells from HLA-A2 or -B7 negative
individuals as target cells. Experiments in which cell-cell con-
tact was prevented showed that the antigen-specific lysis of
HPC was dependent on intimate cell-cell contact between
eff ector-CTLs and bone marrow target cells. Our results show
that this cell-mediated cytotoxicity assay can be used as a
sensitive and specific tool for the study of cellulariy defined
antigens on human hematopoietic progenitor cells.
INTRODUCTION
THE STUDY of polymorphic antigenic determinantson human HPC IS relevant not only for the analysis
of differenüation and regulation of hematopoiesis (1-7)
but also for allogeneic bone marrow transplantation. In
allogeneic bone marrow transplantation cell-mediated lm-
mumty against polymorphic determinants probably plays
an important role m vivo. For mstance, Τ lymphocytes of
the recipient may recognize certam polymorphic antigenic
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determinants on HPC of the donor, leadmg to an lmmune-
mediated rejection of the bone marrow graft (8-11). In
particular, after removal of the immunocompetent Τ lym-
phocytes from the bone marrow graft to prevent acute
graft-versus-host disease, an increase in graft rejections has
been observed (11-15). Donor HPC may be killed in vivo
in a cell-mediated lysis by residual, relatively radiation-
resistant recipient Τ lymphocytes that are not killed by
donor Τ lymphocytes (16). Therefore, smce Τ lymphocyte
depletion of the bone marrow graft is mcreasmgly apphed
in allogeneic bone marrow transplantation, the mapping
of polymorphic determinants on HPC is of major lmpor-
tance. The expression of antigenic determinants on HPC
has been studied using serological techniques such as the
complement-dependent cytotoxicity assay (2, 3, 17) and
fluorescence-activated cell sortmg (1, 3, 4, 18, 19)
However, until now, no in vitro assay has been available
to mvestigate cellulariy defined antigens on human HPC
Such an assay is obhgatory to detect polymorphic antigenic
determinants that cannot be recogmzed serologically (20,
21)
In the present study we have developed a cell-mediated
cytotoxicity assay for the detection of antigenic determi-
nants on human hematopoietic progenitor cells. As a
model we used CTL lines against several HLA class I
antigens
MATERIALS AND METHODS
Establishment of Cytotoxic Τ Lymphocyte (CTL) Lines
CTL lines against HLA-A2 or -B7 determinants were estab-
hshed as previously descnbed (22) Bnefly, Standard mixed lym-
phocyte cultures were estabhshed by incubating HLA-A2 or -B7
negative responder cells at a concentration of 5 x 105 cells/ml
with HLA-A2 or -B7 positive irradiated (15 Gy) stimulator cells
at a concentration of 5 x 105 cells/ml for 6 days in RPMI plus
15% serum (ι e, HEPES-buffered RPMI 1640 with 15% pre-
screened pooled human AB serum supplemented with 0 1 % gen-
tamycm and 10 IHM L-glutamme), at 37°C in an atmosphere of
5% CO2 The effector Τ lymphocytes were harvested and further
expanded for 3-5 days at a concentration of 105 cells/ml in a
medium consisting of 20% Τ cell growth factor (Biotest, Offen-
bach, Germany) in RPMI plus 15% serum at 37°C in an atmos-
phere of 5% CO2 The estabhshed CTL lines were then cryopre-
served at a concentration of 107 cells/ml m a medium consisting
of 70% RPMI, 20% human AB serum, and 10% dimethylsulfox-
lde and stored in liquid nitrogen Before use the CTL lines were
thawed for 1 min in a 37°C water bath, diluted in RPMI plus 50%
serum, washed once in the same medium, and further expanded
for 3-5 days at a concentration of 105 cells/ml in 20% Τ cell
growth factor in RPMI plus 15% serum at 37°C in an atmosphere
of 5% CO2 The cytotoxic reactivity and antigenic specificity of
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the CTL lines were tested usmg a Standard Cr^'-release assay (22)
Surface marker analysis of CTL lines was performed using an
indirect immunoftuorescence technique with munne monoclonal
antibodtes and a fluorescence activated cell sorter (FACS analyzer,
Becton-Dickinson Immunocytometry Systems, Mountain View,
CA) (23) The expression of antigcntc determmants on the eflector
cells was studted with monocional antibodies against the Τ cell
markers CD3 (OKT3, Ortho Diagnostic Systems, Rantan, NJ),
CD4 (Leu 3a, Becton-Dickinson Monocional Center Ine , Moun-
tain View, CA), and CDS (leu 2a, Becton-Dickinson), the Β cel!
markers Leu 12 (Becton-Dickinson) and Β1 (CoulterClone,Coul-
ter Immunology, Hialeah, FL), and HLA-DR (Becton-Dickinson),
as well as using a monocional antibody recogmzing the interleu-
Ιαη-2-receptor (TAC Becton-Dickinson)
Collection of Bone Marrow
Normal human bone marrow οΐ donors for bone marrow
transplantation was obtained, after mformed concent, by aspira-
tion from the postenor iliac crests The cells were coliected in
Hanks balanced salt solution wrth 100 units/ml of preservative-
free hepann The marrow Suspension was diluted in RPMI 1640
with 5% FBS (Gibco, Grand Island, NY) and centnfuged over
Ficoll-Isopaque (1 077 g/cm3, 1,000 g, 20 min, 20°C) The mter-
phase cells were coliected, washed twice in RPMI plus 5% FBS,
and resuspended m the same medium For cryopreservation, bone
marrow mononuclear cells at a concentration of 107 cells/ml were
suspended in a medmm consisting of 70% RPMI, 20% FBS, and
10% dimethylsulfoxide and frozen in a computer-controled
freezer (Cryoson, Middenbeemster, The Netherlands) as previ-
ously desenbed (2) lmmediately before use the cells were thawed
for 1 mm in a 3 7 T waterbath, diluted in HEPES-buffered RPMI
plus 20% FBS at 0°C, washed once in the same medium, and then
washed again in RPMI plus 15% serum The cells were resus-
pended in RPMI plus 15% serum at a concentration of 5 x 10s
viable cells/ml
Cell Mediated Cytotoxicity Assay
Α quantity of I 25 x I0 s bone marrow cells in 0 25 ml RPMI
plus 15% serum was mixed with an equal volume of this medium
containing CTLs The effector-target cell ratios vaned from 1 8 to
16 1 The cell mixlure was cenlnfuged {1,000 g, 15 sec) to establish
cell-cell contact between CTLs and bone marrow cells and then
ineubated for 4 hr m a fully humidified atmosphere of 5% COiat
37"C After incubation, the cells were washed once in RPMI plus
15% serum and resuspended in «-modified Eagle's minimal es-
sential medium (Flow Laboratories, Irvme, Scotland) with 20%
FBS, and subsequentiy eultured for CFU-GM, BFU-E, and CFU-
GEMM As a control to establish the necessity of cell-cell contact
between CTLs and bone marrow cells, and to exelude the possi-
bility of nonspecific Inhibition of hematopoietic progemtor cell
growth due to the presence of cytotoxic cells in the sernisohd
eulture medium CTLs were added to bone marrow celis irame-
diately before plating All CTLs were irradiated (20 Gy) before
use to prevent colony formation by these cells
CFUGM
Α quantity of 105 bone marrow cells was eultured in 1 ml
medium containing 20% FBS (Rehatuin, Kaukakee, IL), 20%
Icukocyte-tonditioncd medium (24), 20% α-modified Eagle's
minimal essentml medium, and 40% methylccllulose 2 25% in a
fully humidified atmosphere of 5% CO2 at 37eC m 35-mm plastic
dishes CFU-GM colonies defined as granulocytic, monocytic, or
eosinophihc aggregates of more than 20 cells were scored on day
10 underan inverted microscope
BFU-E
Α quantity of 10s bone marrow cells was eultured in 1 ml of
medium containmg 20% FBS (Rehatuin), 20% Icukocyte-condi-
tioned medium, 5% 10~3 Μ 2-mercaptoethanol, 5% Iscove's mod-
ified Dulbecco's medium, 5% deionized bovine serum albumin
(Sigma, St Louis, MO), 5% human transfernn, and 40% meth-
ylcellulose 2 8% with I umt/ml erythropoietin (Connaught Step
III, Toronto, Canada) in 35-mm plastic dishes in a fuliy humidi-
fied atmosphere of 5% CO2 at 37'C The number of BFU-E was
scored on day 14
CFU-GEMM
Α quantity of I03 bone marrow cells was eultured in 1 ml
medium containing 30% ABO-compatible human hepann
plasma, 7 5% phytohemagglutinin-Ieukocyte-conditioned me-
dium (25), 5% 10~3 Μ 2-mercaptoethanol, 5% deionized bovme
serum albumin, 5% human tramfernn, 5% Iscove's modified
Dulbecco's medium, and 40% methylcellulose 2 8% with I umt/
ml erythropoietin (2 5%) in 35-mm plastic dishes in a fully
humidified atmosphere of 5% CO2 at 37
eC CFU-GEMM, defined
as colonies containing at least both erythroid and myeloid cells,
was scored on day 14-18
Catculations
100% growth was defined as the number of colonies eultured
from IQ3 untreated bone marrow mononuclear cells The number
of colonies in these eultures was always withm the normal ränge
for our iaboratory (CFU-GM 182 ± 15 (mean ± SE), BFU-E 121
± 12, CFU-GEMM 16 ± 1) In cellular cytotoxicity assays the
percentages of surviving HPC were calculated by dividing the total
number of colonies by the number of colonies in the untreated
control eultures
RESULTS
Characterization of CTL Lines
Table 1 shows the cytotoxic reactivity and antigenic
spectficity of the estabhshed CTL lmes as tested against
phytohemagglutmin-stimulated penpheral blood lympho-
cytes of HLA-A2 or HLA-B7 positive or negative donors
In the Cr5l-release assay at an effector-target ratio of 10· 1
the anti-A2-CTL hne caused a 77 ± 4% lysis of A2~positive
target cells and showed no reactivity (8 ± ! % lysis) against
A2-negative target cells The anti-B7-CTL hne, using the
same effector-to-target ratio, caused 92 ± 1% lysis of B7-
positive target cells and 12 ± 3% lysis of B7-negative target
cells As is shown in Table 1, surface marker analysis of
the CTL hnes showed that most of these cHls were acti-
vated cytotoxic Τ lymphocytes
Cellular Cytotoxicity Assay on Bone Marrow Cells
Pilot studies usmg the anü-A2~CTL hne (Fig 1) showed
that mcubation of these CTLs with A2-negatwe bone
marrow cells did not mfluence plating efficiency of CFU-
GM up to an effector-target ratio of 4.1 Control expen-
ments using noncytotoxic PHA blasts showed similar re-
sults There was no Inhibition of CFU-GM growth after
incubation of PHA blasts witb bone marrow cells up to a
ratio of 8:1
When the anti-A2 CTLs were ineubated with A2-posi-
live bone marrow, Inhibition of CFU-GM growth could
be detected in a dose-dependent manner at effector-target
VOOQT er AI.
Tablo 1 Characterizatlon ol Cytotoxlc T-Lymphocyte-Unes, Using a Cell-Medlated Lympholysls Assay AgalMt PHA-Sttraulated Perlpheral Blood
Lymphocytes
Anti A2 CTL Ifne
AnllB7CTLIine
Responder
HLA Phenotype
A3 A11
B35 B51
A1 A3
B8 B35
Stimulator
HLAPherotype
A2
B51
A1 A3
B7 B8
%Lysls
A2 positive
B7 negativ«
77 ± 4 ·
1 2 ± 3
of Targel Cells
«negative
B7 positive
8 ± r
92 ± 7
Maricer Analysis
(% positive cetis)
C03-94 CD8 75 CD4 23
DR88TAC18B1 1
Leu 122
CD3-S4CD8 69CD412
DB 85 TAC 25 B1 1
Leu 123
* Values are means ± SE of flve experiments Effector target cell ratlo 10 1
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ANTI-Ä2-CTL-LINE
GFU GEMM«n 5
1
EFFECTOR/ TARGET RATIO
Flguro 1 Orowth of CFU GM after fncubatlon of bone marrow cella
wHh the antj A2-CTL llne or noncytotoxic phytohemagglutinin blaata at
varioua effector-target ratloa Black bafs, A2-poattlve bone marrow
cella Incubated with the anri-A2-CTL llne (n = 3), atippled bare, A2-
negatlve bone marrow cella Incubated wHh the anU-A2-CTL llne (n =s
3), whlte bara, bone rnarrow cella Incubated with phytohemagglutinin
blast« (n - 3) Growth Is expreaaed e i a percentage of maximal growth
In untreated control aamplea (meana + SE)
ratios from 1 2 upward Therefore, in further expenments
effector-target ratios varying from 1 2 to 4 1 were used
As shown in Fig 2, by usmg effector-target ratios varying
from 1 2 to 4 1 the anti-A2-CTL line effectively inhibited
the growth of CFU-GM, BFU-E, and CFU-GEMM of A2-
positive bone marrow donors but not of A2-negative in-
dividuals By using the same effector target ratios, mcu-
bation of the bone marrow cells with the anti-B7-CTL 'ine
(Fig 3) resulted in a significant Inhibition of hematopoietic
progemtor cell growth of B7-positive but not B7-negative
individuals Adding the CTLs to the bone marrow cell
culture at an effector-target ratio of 4 1 without ineubation
before platingdid not result in Inhibition of hematopoietic
progenitor cell growth (Table 2)
DISCUSSION
Our results mdicate that the cell-mediated cytotoxicity
assay can be used to investigate the expression of cellularly
defined antigemc determinants on hematopoietic progen-
itor cells
Using CTL hnes against HLA-A2 or -B7 determinants,
we demonstrated that these CTL hnes effectively and
specifically inhibited the growth of CFU-GM, BFU-E, and
CFU-GEMM from A2- or B7-positive bone marrow do-
I
5?
\ \
EFFECTOR / TARGET RATIO
Flgure 2 Growth of CFU-SM, BFU-E, and CFU-GEMM a«er Incu
baHon with the antl-A2-CTL llne al «arloua etfeetor-urget ratlos Ooeed
lymbole, A2-po>ltlve bone marrow cella, open Symbols, A2-negatli«
üone marrow cells Growth is exprassed tu a peiontage of maximal
growth In the untreated control sampjes (meene ± SE)
nors, respectively, whereas no such Inhibition was observed
after treatment of bone marrow cells from A2- or B7-
negative lmdividuals Since relatively Iow effector-target
ratios resulted in an almost complete specific Inhibition of
hematopoietic progenitor cell growth, thts assay appears to
be highly sensitive, although at the highest effector-target
ratios some nonspecific Inhibition occurred
This cell-mediated cytotoxicity assay may be particularly
useful in studying the expression of mmor transplantation
antigens that cannot be recognized serologically (21, 21)
These antigens probably play a major role in the etiology
of graft-versus-host disease after allogeneic bone marrow
transplantation and may conceivably play a role in graft
failure which can occur after Τ lymphocyte depletion of
the bone marrow graft (11-15) Although several patho-
physiological mechanisms may be responsible for this graft
failure, most cases are probably due to Immunologie rejee-
tion of the transplant by the host (11, 13) This view is
supported by the fact that the mcidence of graft failure
after Τ lymphocyte depletion of the bone marrow graft
can be reduced bv more intensive immunosuppressive
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ANTI-B7-CTL-LINE
BFU E « n . i CFU OEMM ·
EFFECTOR,· TAROET RATIO
Figuro 3 Growth ol CFU-GM, BFU-E, and CFU-QEMM alter incu-
bation wlth the antl-87-CTL Ifne at various effector-target ratlos Cfoaed
symbol», B7-posltive bone manrow cells, open Symbols, B7-naflative
bone marrow cells Growth is expressed as a percentage of maximal
growth In the untreated control sample* (means ± SE)
Tflble 2 Qrowth ot Human Hematopoletlc Progenltor Cells In the
Presence of Antigen Speclllc CTLs with or without Incubatlon before
Culture
Incubation
wilh CTU
CTL8 Added to
Cullure Medium
No ol
Experiments
CFU-GM β ± 2·
BFU-E 6 ± 2
CFU-GEMM 1 ± 1
91 ± 6 *
86 ± 1 0
99 ± 2 1
18
7
6
• Values expressed as percentage of maximal colony growth In control
cultures (means ± SE) Results ustng the antl A2 and anti B7-CTL llnes
were pooled Effector target cell ratio 4 1
regimens (11, 15, 26-28) Analysis of the nature of the
effector cells involved, their interaction with bone marrow
target cells, and the target determinants that are recogntzed
in this process require the estabhshment of an in vitro
model The technique descnbed here may be very useful
for this purpose Since the semisohd culture medium pre-
vents cell-cell contract between the effector cells and the
bone marrow target cells, lt is possible, using this assay, to
differentiate between processes that are dependent on cell-
cell contact and other cell-dependent phenomena medi-
ated by soluble factors Particularly in coculture studies
investigating the influence of certain cell populations on
growth of HPC, lt may be important to distinquish between
these processes (29) The assay opens the possibility of
studying whether celt-mediated bone marrow graft rejec-
tion is restncted to polymorphic anügenic determinants or
is due to nonspecific NK-cell-mediated lysis of HPC
In a munne model of graft rejection lt was recently
shown that the rejection process, as detected in vtvo by
prohferative spieen colony assays, could be studied in vitro
using an assay similar to the technique descnbed here (30)
Incubation of bone marrow target cells with spleen-denved
effector cells in vitro resulted in a specific growth Inhibition
of HPC, similar to the Inhibition of HPC observed in vivo
These data indicate that this in vitro assay is analogous to,
and thus a useful model for, the in vivo Situation Η is to
be expected that the cell-mediated cytotoxicity assay we
have descnbed here will be similarly useful in studying the
mechanisms underlying cell-mediated bone marrow graft
rejection in humans
We conclude that this cell-mediated cytotoxicity assay
can be used as a sensitive and specific tool for the analysis
of the expression of cellularly defined polymorphic anti-
gens on hematopoiettc progenitor cells and that this assay
can be apphed to study the mechanisms of cell-mediated
graft rejections in allogeneic bone marrow transplantation
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